Want to see JP:2373 full AI Analyst Report?
Top Page
Care Twentyone Corporation
(2373)
Select Model
Select Model
Rating:56Neutral
Price Target:
¥460.00
▲(10.31% Upside)
Action:Reiterated
Date:09/15/26
Overall score is held back primarily by financial risk from high leverage and very thin margins, despite solid revenue growth and improved recent cash generation. Technicals are supportive with the stock trading above major moving averages, while valuation is reasonable with a moderate P/E and an attractive dividend yield.
Positive Factors
Revenue Growth
Steady multi-year revenue expansion, with sharper acceleration in 2025, indicates the company is continuing to grow its care-services base. A stronger top line can support operating leverage and investment capacity, although conversion into profit remains important over the medium term.
Negative Factors
High Leverage
Debt-to-equity above 4x in 2024–2025 leaves the company highly sensitive to interest-rate changes and operating volatility. Elevated leverage reduces balance-sheet flexibility, constrains capital allocation, and could make it harder to absorb weaker trading conditions over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Steady multi-year revenue expansion, with sharper acceleration in 2025, indicates the company is continuing to grow its care-services base. A stronger top line can support operating leverage and investment capacity, although conversion into profit remains important over the medium term.
Read all positive factors
Care Twentyone Corporation (2373) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.00B
Dividend Yield3.81%
Average Volume (3M)13.88K
Price to Earnings (P/E)21.0
Beta (1Y)0.27
Revenue Growth4.76%
EPS Growth-52.55%
CountryJP
Employees6,319
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)21.25
Shares Outstanding14,844,000
10 Day Avg. Volume26,890
30 Day Avg. Volume13,876
Financial Highlights & Ratios
PEG Ratio0.44
Price to Book (P/B)1.46
Price to Sales (P/S)0.13
P/FCF Ratio3.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Care Twentyone Corporation Business Overview & Revenue Model
Company Description
Care Twentyone Corporation operates as a comprehensive welfare company in Japan. The company offers home care, paid nursing home, dementia group home, in-home care support, small-scale multi-functional home care, day service, and welfare equipment...
Care Twentyone Corporation Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
39
Negative
Cash Flow
62
Positive
| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.98B | 48.16B | 45.40B | 41.10B | 38.40B | 36.36B |
| Gross Profit | 12.10B | 10.62B | 9.19B | 8.61B | 8.97B | 8.51B |
| EBITDA | 2.71B | 2.17B | 937.91M | 1.20B | 2.58B | 2.91B |
| Net Income | 287.66M | 384.18M | 278.42M | 6.16M | 630.49M | 937.08M |
Balance Sheet | ||||||
| Total Assets | 31.17B | 32.09B | 32.94B | 32.88B | 36.38B | 37.60B |
| Cash, Cash Equivalents and Short-Term Investments | 4.50B | 4.17B | 3.08B | 2.61B | 1.88B | 2.83B |
| Total Debt | 18.32B | 18.55B | 19.49B | 18.34B | 22.51B | 22.96B |
| Total Liabilities | 26.42B | 27.60B | 28.21B | 27.36B | 29.90B | 30.83B |
| Stockholders Equity | 4.65B | 4.42B | 4.71B | 5.50B | 6.46B | 6.77B |
Cash Flow | ||||||
| Free Cash Flow | 2.02B | 2.02B | -367.10M | 630.16M | 349.82M | 1.58B |
| Operating Cash Flow | 2.17B | 2.17B | 709.85M | 2.14B | 1.11B | 2.61B |
| Investing Cash Flow | 139.26M | 139.26M | -1.02B | -2.60B | -1.39B | -1.38B |
| Financing Cash Flow | -1.20B | -1.20B | 782.01M | 1.20B | -679.93M | -1.33B |
Care Twentyone Corporation Technical Analysis
Positive
417.00
Price Trends
410.06
Positive
411.90
Positive
419.66
Positive
Market Momentum
9.29
Negative
68.82
Neutral
75.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Positive. The current price of 417 is below the 20-day moving average (MA) of 419.10, above the 50-day MA of 410.06, and below the 200-day MA of 419.66, indicating a bullish trend. The MACD of 9.29 indicates Negative momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 75.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2373.
Care Twentyone Corporation Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.07B | 6.99 | ― | 3.33% | 5.48% | 13.46% | |
70 Outperform | ¥46.73B | 11.58 | ― | 3.30% | 5.16% | 37.79% | |
56 Neutral | ¥6.00B | 21.04 | ― | 3.84% | 4.76% | -52.55% | |
56 Neutral | ¥2.51B | 30.08 | ― | 3.30% | -5.72% | -73.78% | |
55 Neutral | ¥1.36B | 9.35 | ― | 1.70% | 14.48% | 71.76% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:2373
Care Twentyone Corporation
446.00
12.77
2.95%
JP:2425
Care Service Co., Ltd.
663.00
-134.11
-16.82%
JP:6062
Charm Care Corporation
1,433.00
331.83
30.13%
JP:7362
Terminalcare Support Institute, Inc.
890.00
35.24
4.12%
JP:9220
FB CARE SERVICE CO.,LTD.
1,259.00
109.08
9.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.